Aripiprazole

Description

It has been proposed that aripiprazole’s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1A receptors and antagonism of serotonin 5-HT2A receptors.

Medicine classification

ATC Code
Title
Class
Aripiprazole
N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics

Medicines

Drug
Countries

Spain

Australia Austria Canada Cyprus France

Australia

Spain

Spain

Cyprus

Lithuania

Lithuania

Austria

Hong Kong

Lithuania

United States

Spain

Cyprus

United Kingdom

Hong Kong

Spain

Cyprus

Lithuania

Cyprus

Australia

Spain

Cyprus Lithuania Spain

Product monographs

Monograph
Type
Country
MPI, EU: SmPC

2D Molecule Structure

2D representation of molecule

Unique Ingredient Identifier (UNII)

82VFR53I78 - ARIPIPRAZOLE

CAS Registry Number

129722-12-9 - aripiprazole

SNOMED-CT

406784005 - Aripiprazole (substance)